We help our clients and their customers successfully deploy,
protect, maintain, retire and re-use technology.


The world is witnessing explosive growth in the number of connected devices, and in the power and complexity of mobile computing platforms. This is resulting in an increasing need for sophisticated technology- and user support. Regenersis addresses those needs with a growing portfolio of software-rich services building on a strong heritage of repair operations, customer service and data erasure management.

By combining our capabilities in innovative ways, tailored to individual client requirements, we deliver unique service propositions that reinforce trust in our client’s brands and create value for our business partners and shareholders.


Technology Life Cycle Services

Our international network of repair centres provides product repair, refurbishment, parts management and logistics services for mobile, IT, home entertainment and B2B infrastructure product vendors; and their sales channels, insurers, and end users. Our technically-advanced repair capabilities enjoy a solid reputation with our TMT sector clients, combining service excellence with continuous gains in cost efficiency.

Our industry-leading fault diagnostics and issue resolution technologies include the In-Field Tester for set top boxes, and our SmartChk applications suite for smartphones. These advanced diagnostic platforms improve consumer satisfaction with their devices and materially reduce the incidence and cost of product returns for our clients.

In partnership with leading insurers, our Digital Care operations deliver innovative product insurance and extended warranty programmes for our clients, protecting customers’ investments in mobile technology products.

Our Recommerce division helps manufacturers and retailers to launch products and attract new customers through upgrade and buy-back programmes.

Blancco is the global leader in data erasure management (DEM). Blancco software provides comprehensive data erasure for every type of electronic and magnetic storage media, ranging from portable flash drives and mobile phone memory to solid state drives, networked storage, virtual drives and cloud storage. Blancco DEM is a vital part of any organisation’s security infrastructure, underpinning robust data retention policies and ensuring compliance with international data protection regulations.

Regenersis around the world

Our clients increasingly seek partners who can deliver cost-effective and innovative technology life cycle services on a global basis. Since 2011, Regenersis has expanded its geographical footprint from five countries to 16. With the acquisition of Blancco in April 2014, this increased to 22 countries.



http://www.regenersis.com/about-us








Final Results

http://www.moneyam.com/action/news/showArticle?id=4451090

Financial Highlights

·
Group revenue increased by 13% to £139.9 million (2011: £123.8 million)

·
Headline operating profit(*) increased by 24% to £7.8 million (2011: £6.3 million)

·
Operating cash flow improved to £4.9 million (2011: £2.4 million).

·
Further Improvement in headline operating margin to 5.5% (2011: 5.1%)

·
Net debt reduced to £2.9 million (2011: £3.8 million)

·
Banking facility extended from £15 million to £23.25 million for the period to October 2015, to support further organic investment and incremental M&A activity

·
First dividend payment since 2007 - recommended final dividend of 1.1 pence per ordinary share

Glorious indeed DC.

Outlook



· Current trading is in line with market expectations.

· New business wins have progressed very well and are significantly ahead of the run rate at this stage for last year.

· Opportunities for global growth, both organically and by acquisition, remain strong.

· Continuing strong growth expected from Emerging Markets and Advanced Solutions.

· In June 2011, we set out a strategy to target double digit rates of growth in revenue and profits for the following 2-3 years. We have achieved that. Having invested well, we now believe the opportunity exists to continue to grow annually at double digit rates of growth for the foreseeable future.

· Investment in capital expenditure and head office cost growth will continue throughout the business, in order to deliver efficiencies and further growth in 2015 and beyond.



Matthew Peacock, Executive Chairman of Regenersis, said: "Regenersis has delivered another strong performance: from the revenue line down to EPS growth, as well as excellent free cash flow. Consistent with our strategy set out in 2011, the opportunity exists to maintain these levels of growth for the foreseeable future. We have invested in our management team to continue the pace of progress and expect future success."



Enquiries:



Regenersis Plc +44 (0) 20 3657 7000

Matthew Peacock, Executive Chairman

Looking good at the moment.

justposted on twitter......

Equity Development ‏@equity_research 7m
$RGS Regenersis up (another) 2% to new all time high 248p: To join Results Webinar with Management on Thursday SEE: http://tiny.cc/zjhbo

http://www.equitydevelopment.co.uk/

RESEARCH ALERT-Regenersis: Panmure raises price target
24 Sep 2013 - 08:35

Sept 24 (Reuters) - Regenersis PLC : * Panmure raises price target to 302p from 240p; rating buy For a summary of rating actions and price target changes on European companies

The naked trader -

Some of you know I've been building a position in Regenerisis (LON:RGS) in my pension for some time and now I added some to the ISA too.

A superb report yesterday: everything is on the way up and I like the way the company talks about three potential "game changers".

Regenersis PLC (RGS:LSE) set a new 52-week high during today's trading session when it reached 263.20. Over this period, the share price is up 137.12%.

DC broker note out this afternoon....here..........


Dear Mick,





Regenersis released an excellent set of results for the year ended 30 June 2013. Revenue increased by 28% to £179.7m, headline Operating Profit rose by 22% to £9.5m, and adjusted EPS grew by 20% to 16.8p. As a sign of its confidence in the future, the full year dividend is increased by 127% to 2.5p; the Finance Director has also just purchased further shares.




In less than 3 years the Group has been transformed. It has the people, the global reach and deal-making skills to drive earnings forward and to merit a higher rating on those earnings than the current 13.7x forward PER.



Download full report here

Looks good goldfinger, thanks for that.

DC im trying to download the full note........

http://info@equitydevelopment.co.uk

Looks like theirs a glitch. Have you got a subscription with them.

Try doing it from your end. Cant seem to open it.

I just get a sign windows cannot find it ?

Lol, it does say check the spelling and try again. :-))

Even put an ''S'' on the end of development to no avail. lol

Got it in my e-mail.

Might be best to go direct to the site.

Usually do a good note on companys.

See if that works

Regenersis CFO tops up stake as results impress

Tue, 24 September 2013


Jog Dhody, the Chief Financial Officer of Regenersis, on Tuesday acquired 39,000 ordinary shares in the outsourcing partner on the same day it posted "a strong financial performance and good growth" for the year ended June 30th.

Dhody bought the shares a price of 255p per share, spending a total of £99,450. Following the acquisition, he has a beneficial interest of 355,285 shares, representing 0.7% of the company's issued share capital.

In the 12 months to the end of June, the company's revenue increased to £179.7m (2012: £139.9m), while headline operating profit increased to £9.5m (2012: £7.8m) and pre-tax profit of £5.67m (2012: £1.68m).

Net debt fell to £1.9m (FY 2012: £2.9m and HY 2013: £7.7m).

The group recommended a final dividend of 1.83p per ordinary share (2012: 1.1p per share), giving a total dividend for the year of 2.5p per ordinary share (2012: 1.1p) - up 127%.

Looks good for us DC.

We know are onions .......LOL.

lol

I put three threads together for Regenisis, Cranware and Clinigen. Got two right so far. Cranware looked promising but to date has underperformed and do not currently hold. The other two are going fantastic.

Try:

Regenersis - Repaired and Prepared - 25 Sept 2013

Director Deals - Regenersis PLC (RGS)

Tom Russell, Non Executive Director, bought 38,000 shares in the company on the 25th September 2013 at a price of 264.00p. The Director now holds 38,000 shares.